{"url_path":"/sec/cik-0001178879/8-k/2026-04-27/item-2-01","section_key":"item-2-01","section_title":"Item 2.01 Completion of Acquisition or Disposition of Assets.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1178879/0001140361-26-016968-index.html","accession_number":"0001140361-26-016968","cik":"0001178879","ticker":null,"issuer_name":"AMICUS THERAPEUTICS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1178879/0001140361-26-016968-index.html","primary_entity_key":"0001178879","primary_entity_name":"AMICUS THERAPEUTICS, INC."},"word_count":31,"has_tables":true,"body_markdown":"Item 2.01\n\nCompletion of Acquisition or Disposition of Assets.\n\n \n\nThe disclosures under the Introductory Note, Item 3.01, Item 3.03, Item 5.01, Item 5.02 and Item 5.03 are incorporated herein by reference."}